Please login to the form below

Not currently logged in
Email:
Password:

treatment access

This page shows the latest treatment access news and features for those working in and with pharma, biotech and healthcare.

UK’s NICE recommends Roche’s Evrysdi

UK’s NICE recommends Roche’s Evrysdi

Most people with the severest form of the condition, type 1, die before the age of two without treatment. ... administration needs to the NHS In practical terms, the availability of an oral drug should lead to greater adherence to treatment, along with

Latest news

More from news
Approximately 1 fully matching, plus 224 partially matching documents found.

Latest Intelligence

  • EU cross-border healthcare EU cross-border healthcare

    Patients whose very survival depends on therapies that can only be delivered abroad must face a flurry of challenges to access the treatment that will hopefully change their lives forever. ... Furthermore, both pathways are impacted by several challenges

  • Could the rare disease community teach pharma a lesson? Could the rare disease community teach pharma a lesson?

    by Leigh Ansell. Patient support programmes (PSPs) provide help, information and advice to patients, from diagnosis through treatment. ... They get involved with patient organisations, from fundraising and events to advocacy for research funding and

  • Rare genetic diseases – what’s in store for 2021? Rare genetic diseases – what’s in store for 2021?

    The cross-collaboration has also brought forward fundamental changes and breakthroughs for the treatment of many rare genetic diseases. ... We’re looking at digital advances that would improve access to treatment and the overall patient experience.

  • New truths and realities in these strange times New truths and realities in these strange times

    The issue may be as simple as not being able to access their physician/GP in the usual manner, not having the usual access to their medications as regularly (if at ... Patients are also worried about access to care or treatment; the difficulties of

  • Great expectations: the urgent need for common purpose in Alzheimer’s disease Great expectations: the urgent need for common purpose in Alzheimer’s disease

    It will take multiple evolutions before we get an AD treatment equivalent to today’s smartphones. ... Yet a product only succeeds if patients can access it, and smooth market entry in AD.

More from intelligence
Approximately 1 fully matching, plus 54 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 29 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Genetic Digital

Genetic Digital specialises in developing digital marketing solutions for the healthcare, medical and pharmaceutical sectors. From developing a digital strategy,...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...